Companies that handle massive amounts of user data are often the least careful with it. Last year, the National Public Data breach exposed 2.7 billion records. The company’s entire business model was ...
Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...
Expanded cohort reiterates strong adherence rate of over 90% for Shield blood-based colorectal cancer screening test Survey findings show eligible individuals prefer a blood test for colorectal cancer ...
In part 3 of our interview, Jessica K. Paulus, ScD, Ontada, addresses the importance of understanding data sources and their impact on clinical research. Here she continues the data discussion, in the ...
STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced it has provided genomic newborn screenings (gNBS) for ...
Long-term results from a European study showed that prostate cancer mortality was 13% lower in the PSA screening group versus the control group. Compared with the trial update at 16 years, the number ...
DISA Global Solutions, a U.S.-based provider of employee screening services, has said it suffered a data breach that affects more than 3.3 million people. DISA, which provides services like drug and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback